LB30057 inhibits platelet aggregation and vascular relaxation induced by thrombin
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jung, Byoung-In | - |
dc.contributor.author | Kang, Kyu-Tae | - |
dc.contributor.author | Bae, Ok-Nam | - |
dc.contributor.author | Lee, Moo-Yeol | - |
dc.contributor.author | Chung, Seung-Min | - |
dc.contributor.author | Lee, Sang-Koo | - |
dc.contributor.author | Kim, In-Chul | - |
dc.contributor.author | Chung, Jin-Ho | - |
dc.date.accessioned | 2021-06-24T00:45:51Z | - |
dc.date.available | 2021-06-24T00:45:51Z | - |
dc.date.created | 2021-01-21 | - |
dc.date.issued | 2002-12 | - |
dc.identifier.issn | 0253-6269 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/erica/handle/2021.sw.erica/46770 | - |
dc.description.abstract | Previous study showed that an amidrazonophenylalanine derivative, LB30057, which has high water solubility, inhibited the catalytic activity of thrombin potently by interaction with the active site of thrombin. In the current investigation, we examined whether LB30057 inhibited platelet aggregation and vascular relaxation induced by thrombin. Treatment with LB30057 to platelet-rich plasma (PRP) isolated from human blood resulted in a concentration-dependent inhibition of thrombin-induced aggregation. Values for IC50 and IC100 were 54 +/- 4 nM and 96 +/- 3 nM, respectively. This inhibition was agonist (thrombin) specific, since IC50 values for collagen and ADP were much greater than those for thrombin. In addition, concentration-dependent inhibitory effects were observed on the serotonin secretion induced by thrombin in PRP. Consistent with these findings, thrombin-induced increase in cytosolic calcium levels was inhibited in a concentration-dependent manner. When LB30057 was treated with aortic rings isolated from rats, LB30057 resulted in a concentration-dependent inhibition of thrombin-induced vascular relaxation. All these results suggest that LB30057 is a potent inhibitor of platelet aggregation and blood vessel relaxation induced by thrombin. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | 대한약학회 | - |
dc.title | LB30057 inhibits platelet aggregation and vascular relaxation induced by thrombin | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Bae, Ok-Nam | - |
dc.identifier.doi | 10.1007/BF02977008 | - |
dc.identifier.scopusid | 2-s2.0-0038003852 | - |
dc.identifier.wosid | 000180186000022 | - |
dc.identifier.bibliographicCitation | Archives of Pharmacal Research, v.25, no.6, pp.879 - 884 | - |
dc.relation.isPartOf | Archives of Pharmacal Research | - |
dc.citation.title | Archives of Pharmacal Research | - |
dc.citation.volume | 25 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 879 | - |
dc.citation.endPage | 884 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART001002624 | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.subject.keywordPlus | ARGATROBAN | - |
dc.subject.keywordPlus | HEPARIN | - |
dc.subject.keywordPlus | DISEASE | - |
dc.subject.keywordPlus | AGENTS | - |
dc.subject.keywordAuthor | LB30057 | - |
dc.subject.keywordAuthor | platelet-rich plasma | - |
dc.subject.keywordAuthor | thrombin inhibitor | - |
dc.identifier.url | https://link.springer.com/article/10.1007%2FBF02977008 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
55 Hanyangdeahak-ro, Sangnok-gu, Ansan, Gyeonggi-do, 15588, Korea+82-31-400-4269 sweetbrain@hanyang.ac.kr
COPYRIGHT © 2021 HANYANG UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.